PegBio Co., Ltd. (HKG:2565)
Hong Kong
· Delayed Price · Currency is HKD
10.94
+0.36 (3.40%)
Last updated: May 29, 2025
PegBio Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2020 | FY 2019 | FY 2018 |
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 |
| Operating Revenue | - | - | - | 0 | 0 |
| Other Revenue | - | - | - | 0.24 | 0.11 |
| Revenue | - | - | - | 0.24 | 0.11 |
| Revenue Growth (YoY) | - | - | - | 122.72% | - |
| Cost of Revenue | - | - | 4.76 | 0.22 | 0.05 |
| Gross Profit | - | - | -4.76 | 0.02 | 0.06 |
| Selling, General & Admin | 192.43 | 55.36 | 32.32 | 66.39 | 8.64 |
| Research & Development | 95.43 | 236.73 | 95.42 | 151.03 | 87.69 |
| Other Operating Expenses | -0.27 | -2.81 | 0.26 | 0.02 | 0.01 |
| Operating Expenses | 287.59 | 289.28 | 128.08 | 217.47 | 96.35 |
| Operating Income | -287.59 | -289.28 | -132.85 | -217.45 | -96.29 |
| Interest Expense | -2.5 | -1.73 | -3.15 | -1.51 | -0.39 |
| Interest & Investment Income | 0.8 | 5.29 | 1 | 1.03 | 1.03 |
| Currency Exchange Gain (Loss) | - | - | -0.42 | 0.12 | 1.55 |
| Other Non Operating Income (Expenses) | -0.08 | 0.22 | -0.18 | -0.01 | -0.01 |
| EBT Excluding Unusual Items | -289.36 | -285.51 | -135.59 | -217.83 | -94.11 |
| Gain (Loss) on Sale of Investments | 6.01 | 6.33 | - | - | - |
| Other Unusual Items | - | - | 3.67 | 8.23 | 1.13 |
| Pretax Income | -283.35 | -279.18 | -131.92 | -209.6 | -92.98 |
| Earnings From Continuing Operations | -283.35 | -279.18 | -131.92 | -209.6 | -92.98 |
| Minority Interest in Earnings | 0.19 | 0.18 | 1.57 | 2.81 | 1.59 |
| Net Income | -283.16 | -279 | -130.35 | -206.79 | -91.39 |
| Net Income to Common | -283.16 | -279 | -130.35 | -206.79 | -91.39 |
| Shares Outstanding (Basic) | 367 | 362 | 266 | - | - |
| Shares Outstanding (Diluted) | 367 | 362 | 266 | - | - |
| Shares Change (YoY) | 1.40% | 35.93% | - | - | - |
| EPS (Basic) | -0.77 | -0.77 | -0.49 | - | - |
| EPS (Diluted) | -0.77 | -0.77 | -0.49 | - | - |
| Free Cash Flow | -184.32 | -233.9 | -189.12 | -69.04 | -69.49 |
| Free Cash Flow Per Share | -0.50 | -0.65 | -0.71 | - | - |
| Gross Margin | - | - | - | 9.71% | 58.47% |
| Operating Margin | - | - | - | -89706.26% | -88469.31% |
| Profit Margin | - | - | - | -85309.15% | -83965.69% |
| Free Cash Flow Margin | - | - | - | -28482.33% | -63842.09% |
| EBITDA | -286.76 | -287.99 | -131.91 | -216.38 | -95.69 |
| D&A For EBITDA | 0.83 | 1.3 | 0.93 | 1.07 | 0.6 |
| EBIT | -287.59 | -289.28 | -132.85 | -217.45 | -96.29 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.